This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Apr 4;143(14):1320-1322.

doi: 10.1182/blood.2023023714.

Targeting PD-L1 to treat ATLL?

Ambroise Marçais¹

Affiliations

PMID: 38573604
DOI: 10.1182/blood.2023023714

Free article

Editorial

Targeting PD-L1 to treat ATLL?

Ambroise Marçais. Blood. 2024.

Free article

. 2024 Apr 4;143(14):1320-1322.

doi: 10.1182/blood.2023023714.

Author

Ambroise Marçais¹

Affiliation

¹ Hôpital Universitaire Necker Enfants Malades.

PMID: 38573604
DOI: 10.1182/blood.2023023714

No abstract available

PubMed Disclaimer

Comment on

Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma.
Chiba M, Shimono J, Suto K, Ishio T, Endo T, Goto H, Hasegawa H, Maeda M, Teshima T, Yang Y, Nakagawa M. Chiba M, et al. Blood. 2024 Apr 4;143(14):1379-1390. doi: 10.1182/blood.2023021423. Blood. 2024. PMID: 38142436 Free PMC article.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program